<DOC>
	<DOCNO>NCT00199654</DOCNO>
	<brief_summary>The follow colorectal cancer curative surgery find loco-regional relapse synchronous metastasis , detect adenomas new cancer rest colon . The increase survival relapse colorectal cancer depend possibility curative action chemotherapy response . This Phase III open-labeled , multicenter , multidisciplinary , randomise study , compare 2 arm 188 patient ( i.e . 376 total patient ) . Study Period ( date first inclusion/last inclusion ) : 3 year . Follow Up : 3 year . The primary objective evaluation PET performance earlier relapse detection colorectal cancer relapse comparison conventional control ( include carcinoembryonic [ CEA ] level classic radiological exam ) .</brief_summary>
	<brief_title>Positron Emission Tomography ( PET ) Interest Follow Up Colorectal Cancer Stage II III</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>Signed date write informed consent Confirmed stage II III ( TNM ) Patient curative surgery colorectal adenocarcinoma Total digestive endoscopy prior post surgery . Age &gt; 18 year old Normal liver ultrasound chest Xray thoracoabdomino pelvic compute tomography ( CT ) scan . In fertile woman , efficient contraception postmenopausal patient ( amenorrhea least 1 year ) Serious concomitant pathology Uncontrolled diabetes classical treatment ( glycaemia &gt; 1.4 g/l ) Other malignant tumour within last 5 year ( except curatively treat basocellular carcinoma skin situ cervical carcinoma ) . Uncontrolled infection Women pregnant lactate Inability understand inform consent Psychological geographic impossibility follow three year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>colorectal cancer stage II III</keyword>
</DOC>